Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06689137 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effects of Dexmedetomidine on Postoperative Neurocognitive Disorder

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated November 14, 2024 (before its estimated March 15, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
This prospective study involves assessing neurocognitive function in patients undergoing laparotomic gastrointestinal surgery. Mini Mental state Assessment test and Mini-Cog tests will be conducted at multiple intervals preoperatively and postoperatively. Anesthesia management, vital signs, drug consumption, and blood gas values will be recorded throughout the surgery. After all neurocognitive evaluations of the patients are performed at planned intervals for 1 week, the levels of dexmedetomidine and remifentanyl consumed by the patients in the peroperative period will be determined from the anesthesia follow-up sheet and the total duration and amount used will be recorded. At the end of the study, the relationship between neurocognitive values and dexmedetomidine will be compared.
Trial Details
NCT Number NCT06689137
Lead Sponsor Haseki Training and Research Hospital
Conditions
(from sponsor)		 Neurocognitive Disorder, Dexmedetomidine Infusion, Postoperative Cognitive Dysfunction, Postoperative Cognitive Dysfunction(POCD), Laparoscopic Abdominal Surgery
Related terms Neurocognitive Disorders, Postoperative Cognitive Complications
Enrollment 80 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov